AI & BIG DATA
Shaping today's innovations
Save up to 25% on AI & Big Data books, eBooks & Journals
Feigin and Cherry's Textbook of Pediatric Infectious Diseases
2-Volume Set
- 9th Edition - August 29, 2024
- Editors: James Cherry, Sheldon L. Kaplan, Gail J. Demmler-Harrison, William Steinbach, Peter J Hotez, John V Williams
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 8 2 7 6 3 - 8
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 2 7 6 4 - 5
Widely considered the premier text in pediatric infectious diseases, Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 9th Edition: 2-Volume Set, provides auth… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteWidely considered the premier text in pediatric infectious diseases, Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 9th Edition: 2-Volume Set, provides authoritative, up-to-date coverage of this rapidly changing field. Extensively revised by Drs. James Cherry, Sheldon L. Kaplan, Gail J. Demmler-Harrison, William J. Steinbach, Peter J. Hotez, and new editor John V. Williams, this two-volume reference delivers the information you need on epidemiology, public health, preventive medicine, clinical manifestations, diagnosis, treatment, and much more. It serves as a reliable, everyday resource for practicing ID specialists, and an invaluable reference for medical students, residents, and fellows in ID, pediatricians and internists, and others who work with neonates, children, and adolescents or in public health.
- Discusses infectious diseases according to organ systems that may be affected, as well as individually by microorganisms, placing emphasis on clinical manifestations that may be related to the organism causing the disease.
- Provides detailed information regarding the best means to establish a diagnosis, explicit recommendations for therapy, and the most appropriate uses of diagnostic imaging.
- Includes expanded information on Q fever, antibiotic resistance and antibiotic agents, human coronaviruses, pox viruses, and infections in the compromised host, and contains new COVID-19 content across numerous chapters.
- Features a new chapter on antimicrobial stewardship, and new coverage of antivirals for pox viruses.
- Reflects today’s more aggressive infectious and antibiotic-resistant organisms as well as emerging and re-emerging infectious diseases.
- Contains hundreds of full-color images (many are new!), including clinical photos, radiographic images, drawings, charts, and graphs.
- Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. Additional digital ancillary content may publish up to 6 weeks following the publication date.
Pediatric Infectious Disease Specialists (1500 in US), hospital-based pediatricians, and internal medicine docs who see and treat infections in children
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Ralph D. Feigin, MD April 3, 1938–August 14, 2008
- Contributors
- Preface
- VOLUME ONE
- Part I. Host-Parasite Relationships and the Pathogenesis of Infectious Diseases
- 1. Molecular Determinants of Microbial Pathogenesis
- COLONIZATION
- TISSUE TROPISM
- BIOFILMS
- CELL ENTRY AND INTRACELLULAR LIFE
- DAMAGE TO THE HOST
- EVASION OF IMMUNITY
- CONCLUSION
- 2. Normal and Impaired Immunologic Responses to Infection
- HOST-PATHOGEN INTERACTIONS
- FEATURES OF NORMAL IMMUNE FUNCTION
- CLINICAL CONDITIONS ASSOCIATED WITH DEFICIENT HOST RESPONSES TO INFECTION
- EVALUATION FOR IMMUNODEFICIENCY IN THE CHILD WITH RECURRENT OR SEVERE INFECTIONS
- 3. The Host Response to Infections: The “-omics” Revolution
- INTRODUCTION
- GENOMICS
- EPIGENETICS
- TRANSCRIPTOMICS
- PROTEOMICS
- METABOLOMICS
- FUTURE PERSPECTIVES
- 4. Fever: Pathogenesis and Treatment
- NORMAL BODY TEMPERATURE
- THERMOREGULATION
- PATHOGENESIS OF FEVER
- EFFECTS OF FEVER
- CLINICAL THERMOMETRY
- TREATMENT
- SUMMARY
- 5. The Human Microbiome
- INTRODUCTION
- THE HUMAN MICROBIOME: DEVELOPMENT IN EARLY LIFE THROUGH CHILDHOOD
- ENVIRONMENTAL FACTORS AFFECTING THE PEDIATRIC MICROBIOME: DIET AND MEDICATIONS
- THE HUMAN MICROBIOME: PIVOTAL ROLE OF METABOLITES
- MICROBIOME AT DIFFERENT BODY SITES
- SUMMARY
- 6. Epidemiology and Biostatistics of Infectious Diseases
- EPIDEMIOLOGIC STUDIES
- CAUSES OF DISEASE
- BIOSTATISTICS
- DIAGNOSTIC TESTS
- ASSESSMENT OF THE PROTECTIVE EFFICACY OF A VACCINE (OR OF ANY INTERVENTION)
- QUALITY IMPROVEMENT
- Infection of Specific Organ Systems
- Section 1. Upper Respiratory Tract Infections
- 7. The Common Cold
- HISTORY
- ETIOLOGIC AGENTS
- EPIDEMIOLOGY
- PATHOPHYSIOLOGY
- CLINICAL PRESENTATION
- DIFFERENTIAL DIAGNOSIS
- SPECIFIC DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 8. Infections of the Oral Cavity
- MICROBIOLOGIC CONSIDERATIONS IN DENTAL INFECTIONS
- ANATOMIC CONSIDERATIONS
- TREATMENT OF ODONTOGENIC INFECTIONS
- COMPLICATIONS OF ODONTOGENIC INFECTIONS
- OSTEOMYELITIS OF THE JAWS IN CHILDREN
- ORAL MANIFESTATIONS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN CHILDREN
- ORAL CARE OF CHILDREN WITH CANCER
- HERPES SIMPLEX VIRUS INFECTIONS
- ORAL MANIFESTATIONS OF SARS-COV-2
- INTRAORAL AND PERIORAL PIERCINGS
- 9. Pharyngitis (Pharyngitis, Tonsillitis, Tonsillopharyngitis, and Nasopharyngitis)
- HISTORY
- NASOPHARYNGITIS
- PHARYNGITIS, TONSILLITIS, AND TONSILLOPHARYNGITIS
- PERIODIC FEVER, APHTHOUS STOMATITIS, PHARYNGITIS, AND ADENITIS
- 10. Uvulitis
- ETIOLOGY
- EPIDEMIOLOGY
- PATHOGENESIS
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- 11. Peritonsillar, Retropharyngeal, and Parapharyngeal Abscesses
- EPIDEMIOLOGY OF HEAD AND NECK SPACE INFECTIONS IN CHILDREN
- PERITONSILLAR ABSCESS (QUINSY)
- RETROPHARYNGEAL ABSCESS (POSTERIOR VISCERAL SPACE, RETROVISCERAL SPACE, AND RETROESOPHAGEAL SPACE ABSCESSES)
- PARAPHARYNGEAL ABSCESS (PTERYGOMAXILLARY, PHARYNGOMAXILLARY, LATERAL, AND PHARYNGEAL SPACE ABSCESSES)
- MICROBIOLOGY OF DEEP NECK ABSCESSES
- 12. Cervical Lymphadenitis
- EPIDEMIOLOGY
- PATHOPHYSIOLOGY
- CLINICAL PRESENTATION
- DIFFERENTIAL DIAGNOSIS
- SPECIFIC DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 13. Parotitis
- PATHOPHYSIOLOGY
- ETIOLOGY
- CLINICAL PRESENTATION AND DIAGNOSIS
- HUMAN IMMUNODEFICIENCY VIRUS AND PAROTID ENLARGEMENT
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- COMPLICATIONS
- PREVENTION
- 14. Rhinosinusitis
- HISTORY
- ANATOMY
- PATHOPHYSIOLOGY
- ETIOLOGY
- EPIDEMIOLOGY
- CLINICAL PRESENTATION
- COMPLICATIONS
- DIFFERENTIAL DIAGNOSIS
- SPECIFIC DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 15. Otitis Externa
- EPIDEMIOLOGY
- NORMAL ANATOMY
- PROTECTIVE MECHANISMS OF THE EXTERNAL EAR
- NORMAL BACTERIAL FLORA
- ACUTE OTITIS EXTERNA
- CHRONIC OTITIS EXTERNA
- OTOMYCOSIS
- NECROTIZING OTITIS EXTERNA
- DIFFERENTIAL DIAGNOSIS
- PREVENTION
- CONCLUSION
- 16. Otitis Media
- EPIDEMIOLOGY OF ACUTE OTITIS MEDIA
- PATHOGENESIS
- DIAGNOSIS
- EXAMINATION OF THE EAR
- MANAGEMENT OF ACUTE OTITIS MEDIA
- Treatment in the Penicillin-Allergic Child
- OTITIS MEDIA WITH EFFUSION
- RECURRENT ACUTE OTITIS MEDIA
- Immunology
- PREVENTION
- Surgical Options
- COMPLICATIONS AND SEQUELAE
- ACKNOWLEDGMENTS
- 17. Mastoiditis
- HISTORY
- ANATOMY AND PATHOPHYSIOLOGY
- MICROBIOLOGY
- CLINICAL PRESENTATION
- COMPLICATIONS
- DIFFERENTIAL DIAGNOSIS
- SPECIFIC DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 18. Croup (Laryngitis, Laryngotracheitis, Spasmodic Croup, Laryngotracheobronchitis, Bacterial Tracheitis, and Laryngotracheobronchopneumonitis) and Epiglottitis (Supraglottitis)
- HISTORICAL ASPECTS
- TERMINOLOGY
- ETIOLOGY OF CROUP SYNDROMES
- ETIOLOGY OF SUPRAGLOTTITIS
- EPIDEMIOLOGY OF CROUP
- EPIDEMIOLOGY OF SUPRAGLOTTITIS
- PATHOLOGY AND PATHOGENESIS OF CROUP
- ANATOMY AND PATHOPHYSIOLOGY OF SUPRAGLOTTITIS
- CLINICAL PRESENTATION
- DIFFERENTIAL DIAGNOSIS
- SPECIFIC DIAGNOSIS IN CROUP SYNDROMES
- SPECIFIC DIAGNOSIS IN SUPRAGLOTTITIS
- TREATMENT OF CROUP
- TREATMENT OF SUPRAGLOTTITIS
- PROGNOSIS
- PREVENTION OF CROUP
- Section 2. Lower Respiratory Tract Infections
- 19. Acute Bronchitis
- ETIOLOGY
- EPIDEMIOLOGY
- PATHOPHYSIOLOGY AND PATHOLOGY
- CLINICAL PRESENTATION
- DIFFERENTIAL DIAGNOSIS AND SPECIFIC DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 20. Chronic Bronchitis
- DIFFERENTIAL DIAGNOSIS
- EPIDEMIOLOGY AND ETIOLOGY
- TREATMENT
- 21. Bronchiolitis and Infectious Asthma
- DEFINITIONS
- HISTORY
- ETIOLOGIC AGENTS
- EPIDEMIOLOGY
- CLINICAL PRESENTATION
- PATHOPHYSIOLOGY
- DIFFERENTIAL DIAGNOSIS
- DIAGNOSIS
- TREATMENT
- PREVENTION
- COMPLICATIONS AND PROGNOSIS
- 22. Pediatric Community-Acquired Pneumonia
- ETIOLOGY
- EPIDEMIOLOGY
- PATHOGENESIS
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- MANAGEMENT
- PREVENTION
- 23. Empyema and Lung Abscess
- EMPYEMA
- LUNG ABSCESS
- 24. Children’s Interstitial Lung Disease and Hypersensitivity Pneumonitis
- CLASSIFICATION
- CLINICAL PRESENTATION
- DIAGNOSTIC EVALUATION
- TREATMENT
- OUTCOME
- HYPERSENSITIVITY PNEUMONITIS
- 25. Cystic Fibrosis
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- PATHOGENESIS
- SPECIFIC PATHOGENS
- ANAEROBIC BACTERIA
- TREATMENT OF PATHOGENS IN PATIENTS WITH CYSTIC FIBROSIS
- TREATMENT OF PULMONARY EXACERBATIONS
- COVID-19
- CONCLUSION
- Section 3. Infections of the Heart
- 26. Infective Endocarditis
- EPIDEMIOLOGY
- PATHOPHYSIOLOGY
- CLINICAL MANIFESTATIONS
- LABORATORY FINDINGS
- MICROBIOLOGY
- TREATMENT
- PREVENTION
- 27. Infectious Pericarditis
- ANATOMY AND FUNCTION
- BACTERIAL PERICARDITIS
- VIRAL PERICARDITIS
- 28. Myocarditis
- EPIDEMIOLOGY
- ETIOLOGIES
- PATHOLOGY
- PATHOGENESIS
- PATHOPHYSIOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- MOLECULAR DIAGNOSTIC STUDIES
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PROGNOSIS
- MYOCARDITIS IN CASES OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
- PARASITIC MYOCARDITIS
- 29. Acute Rheumatic Fever
- EPIDEMIOLOGY
- PATHOGENESIS
- VACCINE DEVELOPMENT
- RHEUMATIC FEVER IN DEVELOPING COUNTRIES
- PATHOLOGY
- CLINICAL COURSE
- LABORATORY FINDINGS
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- CARDIAC SURGERY
- PROGNOSIS
- PREVENTION OF RHEUMATIC FEVER
- SECONDARY PREVENTION OF RHEUMATIC FEVER
- THE GLOBAL COVID-19 PANDEMIC AND RHEUMATIC FEVER
- CONCLUSION
- 30. Mediastinitis
- ACUTE MEDIASTINITIS
- CHRONIC MEDIASTINITIS
- Section 4. Central Nervous System Infections
- 31. Bacterial Meningitis Beyond the Neonatal Period
- INCIDENCE AND EPIDEMIOLOGY
- PATHOPHYSIOLOGY
- PATHOGENESIS
- PATHOLOGY
- CLINICAL MANIFESTATIONS AND PATHOPHYSIOLOGIC RELATIONSHIPS
- DIFFERENTIAL DIAGNOSIS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS AND SEQUELAE
- PREVENTION
- 32. Parameningeal Infections
- BRAIN ABSCESS
- SUBDURAL EMPYEMA
- EPIDURAL ABSCESS
- SPINAL EPIDURAL INFECTIONS
- 33. Fungal Meningitis
- EPIDEMIOLOGY
- DIAGNOSIS
- CLINICAL MANIFESTATIONS
- 34. Eosinophilic Meningitis
- INTRODUCTION
- EPIDEMIOLOGY
- PATHOGENESIS
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- COURSE AND PROGNOSIS
- PREVENTION
- 35. Aseptic Meningitis and Viral Meningitis
- HISTORY
- ETIOLOGY
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- DIFFERENTIAL DIAGNOSIS
- SPECIFIC DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 36. Encephalitis and Meningoencephalitis
- HISTORY
- ETIOLOGY
- EPIDEMIOLOGY
- PATHOGENESIS
- PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIFFERENTIAL DIAGNOSIS
- EVALUATION OF A PATIENT WITH ENCEPHALOPATHY OR POSSIBLE ENCEPHALITIS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 37. Parainfectious and Postinfectious Demyelinating Disorders of the Central Nervous System
- ACUTE DISSEMINATED ENCEPHALOMYELITIS
- 38. Infection-Associated Myelitis and Myelopathies of the Spinal Cord
- ACUTE TRANSVERSE MYELITIS
- DIAGNOSTIC CRITERIA
- EPIDEMIOLOGY
- CLINICAL PRESENTATION
- RADIOLOGIC FEATURES
- LUMBAR PUNCTURE
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- OUTCOME AND PROGNOSIS
- 39. Guillain-Barré Syndrome
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- SUBTYPES
- DIFFERENTIAL DIAGNOSIS
- PATHOGENESIS
- CLINICAL EVALUATION
- TREATMENT
- OUTCOME AND PROGNOSIS
- Section 5. Genitourinary Tract Infections
- 40. Urethritis
- EPIDEMIOLOGY
- PATHOPHYSIOLOGY
- CLINICAL PRESENTATION
- DIFFERENTIAL DIAGNOSIS
- SPECIFIC DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 41. Cystitis and Pyelonephritis
- EPIDEMIOLOGY
- RISK FOR URINARY TRACT INFECTION
- RISK FACTORS FOR URINARY TRACT INFECTION
- PATHOGENESIS
- CLINICAL PRESENTATION
- DIFFERENTIAL DIAGNOSIS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 42. Renal Abscess
- CLINICAL FINDINGS
- DIAGNOSTIC EVALUATION
- THERAPEUTIC CONSIDERATIONS
- 43. Prostatitis
- CONCLUSION
- 44. Female Genital Infections
- GENERAL APPROACH TO EVALUATION
- NORMAL VAGINAL FLORA
- LOWER GENITAL TRACT INFECTIONS
- SPECIFIC SEXUALLY TRANSMITTED VULVOVAGINITIS
- VULVOVAGINAL LESIONS, ULCERATIONS, AND GRANULOMATOUS INFECTIONS
- Cervicitis
- UPPER GENITAL TRACT INFECTIONS
- Section 6. Gastrointestinal Tract Infections
- 45. Esophagitis
- PATHOPHYSIOLOGY AND CAUSATIVE ORGANISMS
- CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- DIAGNOSIS
- PREVENTION
- TREATMENT
- PROGNOSIS
- 46. Approach to Patients With Gastrointestinal Tract Infections and Food Poisoning
- EPIDEMIOLOGY
- CLINICAL CLASSIFICATION OF DIARRHEA EPISODES
- ORGANISMS THAT CAUSE DIARRHEA
- DIAGNOSIS
- TREATMENT
- PREVENTION
- COVID-19 AND GASTROINTESTINAL MANIFESTATIONS
- 47. Clostridioides difficile Infection
- HISTORY
- EPIDEMIOLOGY
- PATHOGENESIS
- CLINICAL MANIFESTATIONS
- LABORATORY STUDIES
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PREVENTION AND CONTROL
- 48. Whipple Disease
- HISTORY
- EPIDEMIOLOGY
- ETIOLOGY AND PATHOGENESIS
- CLINICAL MANIFESTATIONS
- ACUTE INFECTION
- DIAGNOSIS
- TREATMENT
- CONCLUSION
- Section 7. Liver Diseases
- 49. Hepatitis
- HISTORY
- CLINICAL MANIFESTATIONS AND EVALUATION
- INFECTIOUS CAUSES
- NONINFECTIOUS CAUSES
- 50. Cholangitis and Cholecystitis
- CHOLANGITIS
- ETIOLOGY AND PATHOGENESIS
- CLINICAL PRESENTATION
- DIAGNOSTIC EVALUATION
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PREVENTION
- COMPLICATIONS OF CHOLANGITIS
- SPECIFIC POPULATIONS AND CHOLANGITIS
- CHOLECYSTITIS
- 51. Pyogenic Liver Abscess
- PATHOGENESIS
- MICROBIOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- COMPLICATIONS AND PROGNOSIS
- 52. Reye Syndrome
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS AND LABORATORY FINDINGS
- TREATMENT AND PREVENTION
- Section 8. Other Intraabdominal Infections
- 53. Appendicitis and Pelvic Abscess
- EPIDEMIOLOGY
- PATHOPHYSIOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- MICROBIOLOGY
- TREATMENT
- PROGNOSIS AND RELEVANT INFECTIOUS COMPLICATIONS
- PELVIC ABSCESS
- 54. Pancreatitis
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- CAUSES
- INFECTIOUS CAUSES
- PATHOGENESIS
- TREATMENT
- COMPLICATIONS
- 55. Peritonitis and Intraabdominal Abscess
- PERITONITIS
- INTRAABDOMINAL ABSCESS
- 56. Retroperitoneal Infections
- ETIOLOGY AND PATHOGENESIS
- MICROBIOLOGY
- CLINICAL PRESENTATION
- DIFFERENTIAL DIAGNOSIS
- SPECIFIC DIAGNOSIS
- TREATMENT
- PROGNOSIS
- Section 9. Musculoskeletal Infections
- 57. Osteomyelitis
- INTRODUCTION
- ETIOLOGY OF ACUTE HEMATOGENOUS OSTEOMYELITIS IN CHILDREN IN MICROBIOLOGICALLY CONFIRMED CASES
- HEMATOGENOUS OSTEOMYELITIS
- Differential Diagnosis
- NONHEMATOGENOUS OSTEOMYELITIS
- UNUSUAL MICROBIAL CAUSES OF OSTEOMYELITIS
- CHRONIC OSTEOMYELITIS
- 58. Septic Arthritis
- EPIDEMIOLOGY
- PATHOPHYSIOLOGY
- ETIOLOGY
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PROGNOSIS
- SPECIAL PROBLEMS
- 59. Bacterial Myositis and Pyomyositis
- PYOMYOSITIS
- ACUTE BACTERIAL MYOSITIS
- MISCELLANEOUS CAUSES OF MYOSITIS
- Section 10. Skin Infections
- 60. Cutaneous Manifestations of Systemic Infections
- HISTORY
- ETIOLOGIC AGENTS
- EPIDEMIOLOGY
- PATHOPHYSIOLOGY AND PATHOLOGY OF EXANTHEMS
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT, PROGNOSIS, AND PREVENTION
- 61. Roseola Infantum (Exanthem Subitum)
- HISTORY
- EPIDEMIOLOGY
- ETIOLOGY
- PATHOPHYSIOLOGY
- CLINICAL PRESENTATION
- CLINICAL COMPLICATIONS
- DIAGNOSIS
- TREATMENT AND PROGNOSIS
- 62. Bacterial Skin Infections
- NORMAL SKIN
- CUTANEOUS INFECTION AND DERMATOLOGIC MANIFESTATIONS OF SYSTEMIC DISEASE
- IMPETIGO
- PERIANAL STREPTOCOCCAL DERMATITIS
- BLISTERING DISTAL DACTYLITIS
- ERYSIPELAS
- ECTHYMA
- FOLLICULITIS, FURUNCULOSIS, AND CARBUNCLES
- HIDRADENITIS SUPPURATIVA
- CELLULITIS
- NECROTIZING FASCIITIS
- CONTAMINATED WOUNDS
- 63. Viral and Fungal Skin Infections
- VIRAL INFECTIONS
- FUNGAL INFECTIONS
- Section 11. Ocular Infectious Diseases
- 64. Ocular Infections
- INFECTIONS OF THE EYELIDS
- ANTERIOR EYELID INFECTION
- CONJUNCTIVAL INFECTIONS
- KERATITIS: CORNEAL INFLAMMATION
- INFECTIONS PRIMARILY INVOLVING THE UVEA
- INFECTIONS INVOLVING PRIMARILY THE RETINA
- Section 12. Systemic Infectious Diseases
- 65. Bacteremia and Septic Shock
- PATHOPHYSIOLOGY
- CLINICAL PRESENTATION AND DIAGNOSIS
- TREATMENT
- INVESTIGATIVE THERAPIES
- PROGNOSIS
- 66. Fever Without Source and Fever of Unknown Origin
- FEVER WITHOUT SOURCE
- FEVER OF UNKNOWN ORIGIN
- Acknowledgments
- 67. Toxic Shock Syndrome
- EPIDEMIOLOGY
- HISTOPATHOLOGY
- CLINICAL SPECTRUM
- DIFFERENTIAL DIAGNOSIS
- PREVENTION AND PROPHYLAXIS
- Section 13. Infections of the Fetus and Newborn
- 68. Approach to Infections in the Fetus and Newborn
- VIRAL INFECTIONS OF THE FETUS AND NEONATE
- BACTERIAL DISEASES OF THE FETUS AND NEWBORN
- YEAST AND FUNGAL INFECTIONS OF THE FETUS AND NEONATE
- CONGENITAL TOXOPLASMOSIS
- CHLAMYDIA, MYCOPLASMA, AND UREAPLASMA INFECTIONS IN THE NEONATE
- CONGENITAL SYPHILIS
- Section 14. Infections of the Compromised Host
- 69. Inborn Errors of Immunity (Primary Immunodeficiencies)
- DEFINITIONS AND INTRODUCTION
- EVALUATION FOR SUSPECTED IMMUNODEFICIENCY
- Principles of Management of Primary Immunodeficiencies
- ASSOCIATIONS BETWEEN SPECIFIC PATHOGENS AND PIDDS
- SELECTED IMMUNODEFICIENCIES AFFECTING CELLULAR AND HUMORAL IMMUNITY
- SELECTED COMBINED IMMUNODEFICIENCIES WITH ASSOCIATED OR SYNDROMIC FEATURES
- SELECTED PREDOMINANTLY ANTIBODY DEFICIENCIES
- IgG SUBCLASS “DEFICIENCY”
- SELECTED CONGENITAL DEFECTS OF PHAGOCYTE NUMBER OR FUNCTION
- SELECTED DEFECTS IN INTRINSIC AND INNATE IMMUNITY
- COMPLEMENT DEFICIENCIES
- CONCLUSION
- 70. The Febrile Neutropenic Patient
- EPIDEMIOLOGY OF FEVER AND NEUTROPENIA
- FEVER AND NEUTROPENIA OF UNKNOWN ORIGIN
- RISK STRATIFICATION
- HISTORY AND PHYSICAL EXAMINATION
- INITIAL DIAGNOSTIC EVALUATION
- INITIAL THERAPY FOR FEVER AND NEUTROPENIA
- DIAGNOSTIC EVALUATION FOR PROLONGED FEVER AND NEUTROPENIA
- THERAPEUTIC ADJUSTMENTS FOR PROLONGED FEVER AND NEUTROPENIA
- PREVENTION MEASURES
- 71. Opportunistic Infections in Hematopoietic Stem Cell Transplantation
- EPIDEMIOLOGY
- MAJOR TYPES OF OPPORTUNISTIC INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
- VACCINATIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANT
- 72. Infections in Pediatric Heart Transplantation
- PRETRANSPLANT EVALUATION
- SURGICAL PROPHYLACTIC ANTIBIOTICS
- IMMUNOSUPPRESSION
- IMMEDIATE POSTOPERATIVE INFECTIONS
- INFECTIONS BETWEEN THE FIRST AND SIXTH POSTOPERATIVE MONTHS
- INFECTIONS AFTER THE SIXTH POSTOPERATIVE MONTH
- GASTROINTESTINAL INFECTIONS
- CORONAVIRUS DISEASE 2019 (COVID-19)
- OTHER VIRUSES
- CENTRAL NERVOUS SYSTEM INFECTIONS
- IMMUNOSUPPRESSIVE AGENTS AND ANTIBIOTICS
- IMMUNIZATIONS
- 73. Infections in Pediatric Lung Transplantation
- INTRODUCTION
- Timing of Infection After Transplant
- PRETRANSPLANT EVALUATION
- SELECTED PATHOGENS
- 74. Opportunistic Infections in Liver and Intestinal Transplantation
- PREDISPOSING FACTORS
- TIMING OF INFECTIONS
- BACTERIAL AND FUNGAL INFECTIONS
- VIRAL INFECTIONS
- OPPORTUNISTIC INFECTIONS
- MANAGEMENT
- CONCLUSION
- 75. Infections in Renal Transplantation
- PRETRANSPLANT EVALUATION
- POSTTRANSPLANT INFECTIOUS COMPLICATIONS
- CONCLUSION
- 76. Infections Related to Prosthetic or Artificial Devices
- INTERACTION OF THE HOST WITH A PROSTHETIC DEVICE
- INTERACTION OF MICROORGANISMS WITH A PROSTHETIC DEVICE
- TISSUE EXPANDERS
- COCHLEAR IMPLANTS
- OCULAR PROSTHESES
- LEFT VENTRICULAR ASSIST DEVICES
- EXTRACORPOREAL MEMBRANE OXYGENATION CIRCUITS
- PERMANENT CARDIAC PACEMAKER AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR INFECTIONS
- PROSTHETIC JOINT AND ORTHOPEDIC IMPLANT INFECTIONS
- CEREBROSPINAL FLUID SHUNTS
- INTRACRANIAL PRESSURE MONITORS
- INTRATHECAL PUMP INFUSION DEVICES
- 77. Infections in Burn Patients
- BURN WOUND
- INFLAMMATORY AND IMMUNE RESPONSES IN BURNS
- BURN WOUND MICROBIOLOGY
- CLINICAL MANIFESTATIONS
- MICROBIOLOGIC INVESTIGATIONS
- PREVENTION AND TREATMENT OF INFECTION
- INFECTION CONTROL
- Section 15. Unclassified Infectious Diseases
- 78. Kawasaki Disease
- HISTORY
- EPIDEMIOLOGY
- ETIOLOGY
- Genetic Susceptibility
- PATHOLOGY AND PATHOGENESIS
- CLINICAL MANIFESTATIONS
- INCOMPLETE KAWASAKI DISEASE
- DIFFERENTIAL DIAGNOSIS
- LABORATORY FINDINGS
- MANAGEMENT
- COMPLICATIONS
- LONG-TERM FOLLOW-UP AND PROGNOSIS
- 79. Chronic Fatigue Syndrome (Systemic Exertion Intolerance Disease)
- HISTORICAL OVERVIEW
- EPIDEMIOLOGY
- ETIOLOGY AND PATHOGENESIS
- CLINICAL MANIFESTATIONS
- DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS
- MANAGEMENT
- PROGNOSIS AND FUTURE DIRECTIONS
- Part III. Infections With Specific Microorganisms
- Bacterial Infections
- VOLUME TWO
- Viral Infections
- Subsection I. DNA—Parvoviridae
- 152. Human Parvovirus B19
- HISTORY
- PROPERTIES OF THE VIRUS
- EPIDEMIOLOGY
- PATHOGENESIS AND PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIFFERENTIAL DIAGNOSIS
- DIAGNOSIS
- TREATMENT AND PROGNOSIS
- PREVENTION
- 153. Human Bocaviruses
- HISTORY
- PROPERTIES
- EPIDEMIOLOGY
- IMPACT OF THE COVID-19 PANDEMIC ON HBoV
- PATHOGENESIS
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- Subsection II. DNA—Polyomaviridae
- 154. Human Polyomaviruses
- HISTORY
- VIROLOGY
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- LABORATORY DIAGNOSIS
- TREATMENT AND PREVENTION
- 155. Human Papillomaviruses
- HISTORY
- VIROLOGY
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- LABORATORY DIAGNOSIS
- TREATMENT
- PREVENTION
- FUTURE DIRECTIONS
- Subsection III. DNA—Adenoviridae
- 156. Adenoviruses
- HISTORY
- PROPERTIES OF THE VIRUS
- EPIDEMIOLOGY
- PATHOGENESIS AND PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- PREVENTION
- PROGNOSIS
- Subsection IV. DNA—Hepatoviridae
- 157. Hepatitis B and D Viruses
- Hepatitis B Virus
- Hepatitis D Virus
- Acknowledgment
- Subsection V. DNA—Herpesviridae
- 158. Herpes Simplex Viruses 1 and 2
- THE VIRUSES
- TRANSMISSION
- EPIDEMIOLOGY
- PATHOGENESIS AND PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- PROGNOSIS, COMPLICATIONS, AND SEQUELAE
- POSTINFECTIOUS ENCEPHALITIS
- TREATMENT
- Acknowledgments
- 159. Cytomegalovirus
- HISTORY
- VIROLOGY
- EPIDEMIOLOGY
- PATHOLOGY, PATHOGENESIS, AND IMMUNITY
- CLINICAL MANIFESTATIONS
- LABORATORY DIAGNOSIS
- TREATMENT
- PREVENTION
- 160. Epstein-Barr Virus
- HISTORY
- VIROLOGY
- IMMUNOPATHOGENESIS
- HISTOPATHOLOGY
- EPIDEMIOLOGY
- TRANSMISSION
- NONMALIGNANT CLINICAL SYNDROMES ASSOCIATED WITH EBV INFECTION
- COMPLICATIONS OF INFECTIOUS MONONUCLEOSIS
- MALIGNANT DISEASES ASSOCIATED WITH EPSTEIN-BARR VIRUS
- DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 161. Human Herpesviruses 6A, 6B, 7, and 8
- HUMAN HERPESVIRUSES 6A, 6B, AND 7
- KAPOSI SARCOMA HERPESVIRUS (HUMAN HERPESVIRUS-8)
- 162. Varicella Zoster Virus
- THE ORGANISM
- TRANSMISSION
- EPIDEMIOLOGY
- PATHOGENESIS
- NOSOCOMIAL VARICELLA
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- Subsection VI. DNA—Poxviridae
- 163. Smallpox (Variola Virus)
- HISTORY
- ETIOLOGY
- EPIDEMIOLOGY
- PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIFFERENTIAL DIAGNOSIS
- SPECIFIC DIAGNOSIS
- TREATMENT
- PREVENTION
- 164. Monkeypox and Other Poxviruses
- PROPERTIES OF THE VIRUSES
- SPECIFIC VIRUSES AND THEIR ILLNESSES
- DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS
- 165. Mimiviruses
- STRUCTURE AND PROPERTIES
- VIRAL REPLICATION
- ANIMAL SUSCEPTIBILITY
- MIMIVIRUS INFECTION IN HUMANS
- DIAGNOSTIC METHODS
- MIMIVIRUS AS AN EMERGING PATHOGEN
- TREATMENT AND PREVENTION
- Acknowledgment
- Subsection I. RNA—Picornaviridae
- 166. Enteroviruses, Parechoviruses, and Saffold Viruses
- HISTORY
- THE VIRUSES
- EPIDEMIOLOGY
- PATHOGENESIS
- PATHOLOGY
- CLINICAL MANIFESTATIONS: NONPOLIO ENTEROVIRUSES, PARECHOVIRUSES, AND SAFFOLD VIRUSES
- NEONATAL INFECTIONS
- CLINICAL MANIFESTATIONS: POLIOVIRUS
- DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PREVENTION
- Acknowledgments
- 167. Rhinoviruses
- HISTORY
- ORGANISM
- EPIDEMIOLOGY
- PERSON-TO-PERSON TRANSMISSION
- PATHOGENESIS AND HOST FACTORS
- CLINICAL MANIFESTATIONS
- DIAGNOSIS OF INFECTION
- PREVENTION AND TREATMENT
- Acknowledgments
- 168. Hepatitis A Virus
- INTRODUCTION
- EPIDEMIOLOGY
- VIROLOGY
- PREVENTION
- TREATMENT
- SUMMARY
- Subsection II. RNA—Caliciviridae
- 169. Caliciviruses
- VIROLOGIC FEATURES
- EPIDEMIOLOGY
- PATHOGENESIS
- IMMUNE RESPONSE
- CLINICAL MANIFESTATIONS
- DIFFERENTIAL DIAGNOSIS
- DIAGNOSIS
- TREATMENT AND PREVENTION
- PROGNOSIS
- 170. Hepatitis E Virus
- HISTORY AND DISCOVERY OF VIRUS
- MICROBIOLOGY AND GENOME ORGANIZATION
- EPIDEMIOLOGY
- PATHOGENESIS AND IMMUNITY
- CLINICAL MANIFESTATIONS
- DIAGNOSTIC TESTING
- DISEASE PREVENTION AND VACCINE CANDIDATES
- SUMMARY
- Subsection III. RNA—Reoviridae
- 171. Reoviruses
- HISTORY
- PROPERTIES
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- 172. Orbiviruses, Coltiviruses, and Seadornaviruses: Colorado Tick Fever, Banna Virus, and Others
- COLORADO TICK FEVER VIRUS
- BANNA VIRUS
- KEMEROVO AND RELATED VIRUSES
- ORUNGO VIRUS
- LEBOMBO VIRUS
- CHANGUINOLA VIRUS
- Acknowledgment
- 173. Rotavirus
- ROTAVIRUSES
- ROTAVIRUS INFECTION
- ROTAVIRUS DISEASE
- EPIDEMIOLOGY
- LABORATORY DIAGNOSIS
- TREATMENT
- ROTAVIRUS IMMUNITY
- ROTAVIRUS VACCINES
- Subsection IV. RNA—Togaviridae
- 174. Rubella Virus
- HISTORY
- PROPERTIES
- EPIDEMIOLOGY
- PATHOLOGY AND PATHOGENESIS
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- PREVENTION
- 175. Eastern Equine Encephalitis
- ETIOLOGIC AGENT
- ECOLOGY
- EPIDEMIOLOGY
- PATHOLOGY
- PATHOGENESIS
- CLINICAL MANIFESTATIONS
- PROGNOSIS AND SEQUELAE
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PREVENTION
- Acknowledgment
- 176. Western Equine Encephalitis
- ETIOLOGIC AGENT
- ECOLOGY
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY
- PATHOGENESIS
- PROGNOSIS
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PREVENTION
- Acknowledgment
- 177. Venezuelan Equine Encephalitis
- ETIOLOGIC AGENT
- EPIDEMIOLOGY AND ECOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY AND PATHOGENESIS
- LABORATORY DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PREVENTION
- Acknowledgment
- 178. Chikungunya
- ETIOLOGIC AGENT
- ZOONOTIC CYCLES
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOGENESIS AND PATHOLOGY
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 179. Ross River Virus Arthritis
- ETIOLOGIC AGENT
- TRANSMISSION AND EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY
- DIAGNOSIS
- TREATMENT AND PROGNOSIS
- PREVENTION
- Acknowledgments
- 180. Other Alphaviral Infections
- O’NYONG-NYONG
- IGBO-ORA FEVER
- BARMAH FOREST FEVER
- SINDBIS FEVER
- MAYARO FEVER
- SEMLIKI FOREST VIRUS FEVER
- Acknowledgment
- Subsection V. Flaviviridae
- 181. St. Louis Encephalitis
- ETIOLOGIC AGENT
- ECOLOGY
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY
- PATHOGENESIS
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- Acknowledgment
- 182. West Nile Virus
- History
- Virology
- Epidemiology
- Pathogenesis
- Clinical Manifestations
- Outcome
- Laboratory Findings
- Electrodiagnostic Studies
- Neuroimaging
- Viral Culture And Nucleic Acid Amplification Detection of West Nile Virus
- Detection of West Nile Virus–Specific Antibodies
- Neuropathology
- Treatment
- Prevention
- Acknowledgment
- 183. Yellow Fever
- HISTORY
- ETIOLOGIC AGENT
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY
- LABORATORY FINDINGS
- DIFFERENTIAL DIAGNOSIS
- LABORATORY DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION AND CONTROL
- 184. Dengue, Dengue Hemorrhagic Fever, and Severe Dengue
- ETIOLOGIC AGENTS
- TRANSMISSION
- HISTORY
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY AND PATHOGENESIS
- DIAGNOSIS
- LABORATORY STUDIES
- TREATMENT
- REGULATORY MEASURES
- PROGNOSIS
- PREVENTION
- 185. Japanese Encephalitis
- HISTORY
- ETIOLOGIC AGENT
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY
- PATHOPHYSIOLOGY
- COMPLICATIONS
- LABORATORY DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 186. Murray Valley Encephalitis
- ETIOLOGIC AGENT
- TRANSMISSION AND EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY
- DIAGNOSIS
- TREATMENT AND PROGNOSIS
- PREVENTION
- 187. Tick-Borne Encephalitis
- HISTORY
- ETIOLOGIC AGENT
- ECOLOGY
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY
- PATHOGENESIS
- LABORATORY DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 188. Zika Virus Infections
- EPIDEMIOLOGY
- VIROLOGY AND PATHOGENESIS
- CLINICAL MANIFESTATIONS AND COMPLICATIONS
- ZIKV DIAGNOSIS, MANAGEMENT, THERAPEUTICS, AND PREVENTION
- EVALUATION AND MANAGEMENT OF PEDIATRIC PATIENTS WITH ZIKV
- ZIKV PREVENTION: VECTOR CONTROL, VACCINES, AND OTHER CHALLENGES
- CONCLUSION
- 189. Other Less Commonly Recognized Flaviviruses
- Powassan Viral Encephalitis
- Rocio Viral Encephalitis
- Louping Ill Virus
- Kyasanur Forest Disease
- Omsk Hemorrhagic Fever
- Other Flaviviral Infections
- 190. Hepatitis C Virus
- HISTORY
- VIROLOGY
- PATHOGENESIS
- VIRAL LIFE CYCLE
- EPIDEMIOLOGY
- VIRAL GENETICS
- TRANSMISSION
- CLINICAL MANIFESTATIONS
- IMMUNITY
- DIAGNOSIS
- TREATMENT
- PREVENTION AND COUNSELING
- SUMMARY
- Subsection VI. Orthomyxoviridae
- 191. Influenza Viruses
- HISTORY
- BIOLOGY
- ECOLOGY
- SURVEILLANCE
- EVOLUTION AND ADAPTATION
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY
- PATHOGENESIS
- DIAGNOSIS
- MANAGEMENT
- INFECTION CONTROL
- VACCINES
- EFFICACY AND EFFECTIVENESS
- PANDEMIC PREPAREDNESS
- Subsection VII. Paramyxoviridae
- 192. Parainfluenza Viruses
- HISTORY
- CHARACTERIZATION OF PARAINFLUENZA VIRUSES
- EPIDEMIOLOGY
- PATHOGENESIS
- IMMUNE RESPONSE: ROLE IN PATHOGENESIS AND PROTECTION
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- MANAGEMENT AND THERAPY
- PROGNOSIS
- PREVENTION
- 193. Measles Virus
- HISTORY
- PROPERTIES
- EPIDEMIOLOGY
- PATHOGENESIS AND PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIFFERENTIAL DIAGNOSIS
- DIAGNOSIS
- TREATMENT
- PREVENTION
- 194. Mumps Virus
- HISTORY
- CLASSIFICATION
- PROPERTIES
- EPIDEMIOLOGY
- PATHOGENESIS
- PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIFFERENTIAL DIAGNOSIS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 195. Respiratory Syncytial Virus
- HISTORY
- STRUCTURAL AND ANTIGENIC PROPERTIES
- EPIDEMIOLOGY
- PATHOLOGY AND PATHOGENESIS
- IMMUNITY AND DISEASE PATHOGENESIS
- CLINICAL MANIFESTATIONS
- PROGNOSIS
- DIAGNOSIS
- TREATMENT
- PREVENTION
- Acknowledgment
- 196. Human Metapneumovirus
- HISTORY
- PROPERTIES
- EPIDEMIOLOGY
- PATHOGENESIS AND PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIFFERENTIAL DIAGNOSIS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- Subsection VIII. Rhabdoviridae
- 197. Rabies Virus
- HISTORY
- ETIOLOGY
- TRANSMISSION AND EPIDEMIOLOGY
- COVID-19 AND RABIES
- PATHOBIOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- PROPHYLAXIS
- PREEXPOSURE IMMUNIZATION
- FUTURE DEVELOPMENTS
- Acknowledgments
- Subsection IX. Arenaviridae and Filoviridae
- 198. Lymphocytic Choriomeningitis Virus
- HISTORY
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- CONCLUSION
- 199. Arenaviral Hemorrhagic Fevers
- HISTORY
- ETIOLOGIC AGENTS
- Person-to-Person Transmission
- CLINICAL MANIFESTATIONS
- PATHOGENESIS AND PATHOLOGY
- DIAGNOSIS
- PROGNOSIS AND TREATMENT
- PREVENTION AND CONTROL
- Acknowledgment
- 200. Filoviral Hemorrhagic Fever: Marburg and Ebola Virus Fevers
- ETIOLOGIC AGENTS
- HISTORY AND EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY
- DIFFERENTIAL DIAGNOSIS
- DIAGNOSIS
- INFECTION CONTROL, PREVENTION, AND TREATMENT
- CONCLUSION
- Subsection X. Coronaviridae and Torovirdae
- 201. Human Coronaviruses
- BACKGROUND
- VIROLOGY
- EPIDEMIOLOGY OF COMMON COLD RESPIRATORY CORONAVIRUSES
- INFECTION AND IMMUNITY
- CLINICAL MANIFESTATIONS OF RESPIRATORY TRACT INFECTIONS
- LABORATORY DIAGNOSIS
- PREVENTION AND TREATMENT
- SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
- Subsection XI. Bunyaviridae
- 202. Hantaviruses
- Historical Perspective
- Organism
- Epidemiology
- Clinical Manifestations
- Complications
- Pathogenesis And Pathology
- Diagnosis And Differential Diagnosis
- Treatment
- Prevention
- 203. La Crosse Virus and Other California Serogroup Viruses
- ETIOLOGIC AGENT
- ECOLOGY
- EPIDEMIOLOGY
- PATHOGENESIS
- CLINICAL MANIFESTATIONS
- LABORATORY AND RADIOLOGIC DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- OUTCOME
- PATHOLOGY
- PREVENTION
- 204. Rift Valley Fever
- HISTORY
- ETIOLOGIC AGENT
- VECTORS AND EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- LABORATORY FINDINGS
- TREATMENT
- PREVENTION
- 205. Crimean-Congo Hemorrhagic Fever
- ETIOLOGIC AGENT
- EPIDEMIOLOGY
- PATHOGENESIS
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 206. Phlebotomus Fever (Sandfly Fever)
- ETIOLOGIC AGENT
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOLOGY
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- Acknowledgment
- 207. Oropouche Fever
- ETIOLOGIC AGENT AND MOLECULAR AND SEROLOGIC CLASSIFICATION
- EPIDEMIOLOGY
- CLINICAL MANIFESTATIONS
- PATHOGENESIS
- LABORATORY FINDINGS
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- TREATMENT
- PREVENTION AND CONTROL
- 208. Toscana Virus
- HISTORY
- ETIOLOGIC AGENT
- EPIDEMIOLOGY
- CYCLE IN NATURE
- CLINICAL MANIFESTATIONS
- DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS
- GENETIC DIVERSITY OF TOSCANA VIRUS
- Subsection XII. Retroviridae
- 209. Oncoviruses (Human T-Cell Lymphotropic Viruses) and Lentiviruses (Human Immunodeficiency Virus Type 2)
- CLASSIFICATION
- ONCOVIRUSES: HUMAN T-CELL LYMPHOTROPIC VIRUS TYPES
- LENTIVIRUSES: HUMAN IMMUNODEFICIENCY VIRUS TYPE 2
- 210. Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome
- Epidemiology of Pediatric HIV Infection
- Staging of Pediatric HIV Infection
- Transmission And Prevention
- Etiology
- Pathogenesis
- Clinical Manifestations
- Complications
- Diagnosis of HIV Infection In Infants And Children
- Immunologic And Clinical Monitoring of Children Living With HIV
- Treatment
- CAPSID INHIBITORS
- Subsection XIII. Prion-Related Diseases
- 211. Transmissible Spongiform Encephalopathies (Creutzfeldt-Jakob Disease, Gerstmann-Sträussler-Scheinker Disease, Kuru, Fatal Familial Insomnia, New Variant Creutzfeldt-Jakob Disease, Sporadic Fatal Insomnia, Variably Protease Sensitive Prionopathy)
- HISTORY
- EPIDEMIOLOGY AND NATURAL HISTORY
- ETIOLOGIC AGENT AND PATHOGENESIS
- PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- PREVENTION
- Section 18. Chlamydia
- 212. Chlamydia Infections
- Infections Caused by Chlamydia trachomatis
- Infection Caused by Chlamydia pneumoniae
- Section 19. Rickettsial Diseases
- 213. Rickettsial and Ehrlichial Diseases
- SPOTTED FEVERS
- TYPHUS
- EHRLICHIOSIS AND ANAPLASMOSIS
- Section 20. Mycoplasma
- 214. Mycoplasma and Ureaplasma Infections
- HISTORY
- CLASSIFICATION
- MYCOPLASMOIDES PNEUMONIAE
- UREAPLASMA
- METAMYCOPLASMA HOMINIS
- MYCOPLASMOIDES GENITALIUM
- MYCOPLASMOPSIS FERMENTANS
- MALACOPLASMA PENETRANS
- DIAGNOSIS OF GENITAL MYCOPLASMAS
- OTHER MYCOPLASMA SPECIES AND MYCOPLASMA RELATIONSHIPS
- TREATMENT OF GENITAL MYCOPLASMAS
- PREVENTION OF GENITAL MYCOPLASMAS
- Section 21. Fungal Diseases
- 215. Aspergillosis
- ORGANISM
- CLINICAL PRESENTATIONS
- EPIDEMIOLOGY
- DIAGNOSIS
- TREATMENT
- 216. Blastomycosis
- HISTORICAL PERSPECTIVE
- MYCOLOGY
- ECOLOGY AND EPIDEMIOLOGY
- PATHOGENESIS
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- 217. Candidiasis
- ORGANISM
- EPIDEMIOLOGY
- RISK FACTORS
- PATHOGENESIS
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- ANTIFUNGAL PROPHYLAXIS AND TREATMENT
- NEONATAL CANDIDIASIS
- 218. Coccidioidomycosis
- EPIDEMIOLOGY
- PATHOGENESIS AND PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 219. Paracoccidioidomycosis
- THE ORGANISM
- TRANSMISSION
- EPIDEMIOLOGY
- PATHOGENESIS AND PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- Acknowledgments
- 220. Cryptococcosis
- ORGANISM
- ECOLOGY AND EPIDEMIOLOGY
- PATHOGENESIS
- PULMONARY CRYPTOCOCCOSIS
- CRYPTOCOCCAL MENINGOENCEPHALITIS
- IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME
- OTHER FORMS OF CRYPTOCOCCOSIS
- TREATMENT
- 221. Histoplasmosis
- ORGANISM
- EPIDEMIOLOGY
- PATHOPHYSIOLOGY
- PATHOLOGY
- CLINICAL MANIFESTATIONS
- RADIOGRAPHIC FINDINGS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS
- PREVENTION
- 222. Sporotrichosis
- ORGANISM
- EPIDEMIOLOGY
- PATHOGENESIS AND PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- PROGNOSIS AND PREVENTION
- 223. Mucormycosis and Entomophthoramycosis
- MUCORMYCOSIS
- ENTOMOPHTHORAMYCOSIS
- 224. Fusariosis and Scedosporiosis
- INFECTIONS CAUSED BY FUSARIUM SPECIES
- INFECTIONS CAUSED BY SCEDOSPORIUM SPECIES
- 225. Miscellaneous Mycoses
- YEASTS
- MOLDS
- Parasitic Diseases
- Subsection I. Protozoa
- 226. Amebiasis
- ETIOLOGY
- EPIDEMIOLOGY
- PATHOGENESIS AND PATHOLOGY
- IMMUNITY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- COMPLICATIONS
- TREATMENT
- PROGNOSIS
- FUTURE CONSIDERATIONS
- 227. Blastocystis hominis and Blastocystis spp. Infection
- ETIOLOGY AND PATHOGENESIS
- EPIDEMIOLOGY AND CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- 228. Entamoeba coli Infection
- Etiology and Pathogenesis
- Epidemiology and Clinical Manifestations
- Diagnosis and Treatment
- 229. Giardiasis
- Organism and Etiology
- Epidemiology
- Pathogenesis
- Clinical Manifestations
- Diagnosis
- Treatment
- 230. Dientamoeba fragilis Infections
- Organism
- Epidemiology and Transmission
- Clinical Manifestations
- Diagnosis
- Treatment
- 231. Trichomonas Infections
- MICROBIOLOGY
- PATHOLOGY AND PATHOGENESIS
- EPIDEMIOLOGY
- CLINICAL DIAGNOSIS AND SURVEILLANCE
- TREATMENT
- 232. Balantidium coli Infection
- Etiology and Pathogenesis
- Epidemiology
- Clinical Manifestations
- Diagnosis
- Treatment
- 233. Cryptosporidiosis
- Microbiology
- Life Cycle
- Epidemiology
- Transmission
- Pathology and Pathogenesis
- Immunology
- Clinical Manifestations
- Diagnosis
- Management
- Prevention
- 234. Cyclosporiasis, Cystoisosporiasis, and Microsporidiosis
- CYCLOSPORA CAYETANENSIS
- CYSTOISOSPORIASIS
- Microbiology and Life Cycle
- MICROSPORIDIOSIS
- 235. Babesiosis
- ECOLOGY
- EPIDEMIOLOGY
- PATHOGENESIS AND PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- PREVENTION AND TREATMENT
- 236. Malaria
- HISTORY
- ORGANISM
- EPIDEMIOLOGY
- TRANSMISSION
- HOST-PARASITE INTERACTION
- PATHOPHYSIOLOGY
- CLINICAL MANIFESTATIONS AND LABORATORY FINDINGS
- DIAGNOSIS
- TREATMENT
- PREVENTION
- 237. Leishmaniasis
- ORGANISM
- EPIDEMIOLOGY
- OLD WORLD CUTANEOUS LEISHMANIASIS
- AMERICAN CUTANEOUS LEISHMANIASIS
- VISCERAL LEISHMANIASIS
- COINFECTION WITH COVID-19 AND LEISHMANIASIS
- 238. Trypanosomiasis
- AMERICAN TRYPANOSOMIASIS (CHAGAS DISEASE)
- AFRICAN TRYPANOSOMIASIS (SLEEPING SICKNESS)
- 239. Naegleria, Acanthamoeba, and Balamuthia Infections
- EPIDEMIOLOGY
- ORGANISMS
- CLINICAL MANIFESTATIONS
- NEUROIMAGING
- PATHOGENESIS
- PATHOLOGY
- DIAGNOSIS
- TREATMENT
- ROLE OF ACANTHAMOEBA SPECIES AS RESERVOIRS OF INTRACELLULAR PATHOGENS
- PREVENTION
- 240. Toxoplasmosis
- ORGANISM AND TRANSMISSION
- EPIDEMIOLOGY
- PATHOLOGY
- IMMUNOLOGY
- CLINICAL SYNDROMES
- LABORATORY DIAGNOSIS
- TREATMENT
- PREVENTION
- Acknowledgments
- 241. Pneumocystis Pneumonia
- ORGANISM
- TRANSMISSION AND EPIDEMIOLOGY
- IMMUNOPATHOGENESIS
- PATHOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- PROGNOSIS
- TREATMENT
- PREVENTION
- Subsection II. Nematodes
- 242. Parasitic Nematode Infections
- INTESTINAL NEMATODES
- ABERRANT INFECTIONS WITH INTESTINAL NEMATODES
- OTHER ABERRANT INFECTIONS WITH INTESTINAL NEMATODES
- FILARIAL PARASITES
- Subsection III. Cestodes
- 243. Cestodes
- Overview of Cestodes and their Importance for Children
- Taenia Saginata (Beef Tapeworm) Infection
- Taenia Asiatica (Asian Pork Tapeworm)
- Taenia Solium
- Coenurosis (Taenia Multiceps, Others) and Cysticercosis Caused by Taenia Crassiceps
- Dibothriocephalus Spp. and Adenocephalus Spp. (Fish Tapeworm)
- Dipylidium Caninum (Dog Tapeworm)
- Hymenolepis Nana (Dwarf Tapeworm)
- Hymenolepis Diminuta (Rat Tapeworm)
- Sparganosis (Intermediate-Stage Spirometra Species Infection)
- Echinococcus Granulosus Sensu Lato and Related Species (Cystic Hydatid Disease)
- Other Echinococcus Species
- Subsection IV. Trematodes
- 244. Foodborne Trematodes
- Liver Flukes
- Lung Fluke
- Intestinal Flukes
- 245. Schistosomiasis
- INTRODUCTION
- EPIDEMIOLOGY
- PATHOGENESIS AND IMMUNITY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS
- TREATMENT
- PREVENTION
- Subsection V. Arthropods
- 246. Arthropods
- Ticks
- Mites
- Lice
- Bed Bugs
- Spiders
- Scorpions
- Fleas
- Section 23. Global Health
- 247. Global Health
- DEFINITION OF GLOBAL HEALTH
- HISTORY AND EVOLUTION OF GLOBAL HEALTH
- SOCIAL DETERMINANTS OF HEALTH
- GLOBAL GOALS FOR GLOBAL HEALTH
- FUTURE DIRECTION OF GLOBAL HEALTH
- 248. International Travel Considerations for Children
- PEDIATRIC TRAVELERS VISITING FRIENDS AND RELATIVES
- PRETRAVEL CONSULTATIONS FOR CHILDREN
- PEDIATRIC TRAVELERS AND HEALTH RISKS ABROAD
- GENERAL APPROACH TO PRETRAVEL ASSESSMENT FOR CHILDREN
- SPECIAL CONSIDERATIONS FOR MEDICAL HISTORY
- THE TRAVEL ITINERARY
- VACCINATION FOR INTERNATIONAL TRAVEL
- PREVENTION OF TRAVELERS’ DIARRHEA IN CHILDREN
- PREVENTION OF OTHER INFECTIOUS DISEASES IN PEDIATRIC TRAVELERS
- EMERGENCY MEDICAL CARE DURING TRAVEL
- RESOURCES FOR PEDIATRIC TRAVELERS
- Acknowledgments
- 249. Infectious Disease Considerations in International Adoptees and Refugees
- OVERALL EVALUATION
- INFECTIOUS DISEASE SCREENING
- OTHER VACCINE-PREVENTABLE DISEASES
- IMMUNIZATION GUIDELINES
- CONCLUSION
- Part IV. Therapeutics
- 250. Antibiotic Resistance
- Resistance Genetics
- Resistance to Specific Antibiotics
- The Intersection of Covid-19 and Antimicrobial Resistance
- 251. The Pharmacokinetic-Pharmacodynamic Interface: Determinants of Antiinfective Drug Action and Efficacy in Pediatrics
- PHARMACOKINETIC DETERMINANTS OF EXPOSURE
- BASIC TERMS
- IMPACT OF ONTOGENY ON PHARMACOKINETICS
- PHARMACOKINETIC DETERMINANTS OF EFFECT
- PHARMACODYNAMIC DETERMINANTS OF EFFECT
- PHARMACOGENETIC-PHARMACOGENOMIC DETERMINANTS OF EFFECT
- MODEL INFORMED DRUG DEVELOPMENT FOR ANTIIFECTIVE USE IN PEDIATRICS
- CONCLUSIONS AND IMPLICATIONS FOR PRECISION THERAPEUTICS IN INFECTIOUS DISEASE
- 252. Antibacterial Therapeutic Agents
- CLINICAL PHARMACOLOGY
- AGENTS THAT TARGET THE CELL WALL
- AGENTS THAT TARGET PROTEIN SYNTHESIS
- AGENTS THAT TARGET NUCLEIC ACIDS
- SELECTED ASPECTS OF THE ADMINISTRATION OF ANTIMICROBIAL AGENTS
- SUMMARY AND CONCLUSIONS
- 253. Antimicrobial Prophylaxis
- GENERAL PRINCIPLES OF PROPHYLAXIS
- PROPHYLAXIS IN NEONATES
- DISEASE-TARGETED PROPHYLAXIS
- COVID-19 INFECTION
- POSTEXPOSURE PROPHYLAXIS
- HOST-TARGETED PROPHYLAXIS
- SURGICAL PROPHYLAXIS
- 254. Outpatient Intravenous Antimicrobial Therapy for Serious Infections
- EVALUATING A CHILD AND PARENTS FOR OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY
- THE OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY PROGRAM
- Selection of an Antimicrobial Agent
- Delivery of Antimicrobial Agents
- OUTCOME ANALYSIS
- SUMMARY
- 255. Antiviral Agents
- Antiviral Agents Active Against RNA Viruses
- Antiviral Agents Active Against DNA Viruses
- 256. Antifungal Agents
- AGENTS FOR TREATMENT OF INVASIVE MYCOSES
- Agents for Systemic Treatment of Mycoses of the Skin and Its Appendages
- TOPICAL ANTIFUNGAL AGENTS
- FUTURE DIRECTIONS
- 257. Drugs for Parasitic Infections
- 258. Immunomodulating Agents
- MICROBIOME
- VACCINATIONS AND VACCINES
- MONOCLONAL ANTIBODIES
- CYTOKINES
- INTERFERONS
- TOLL-LIKE RECEPTORS
- NEUTROPHILS AND COMPLEMENT
- BACTERICIDAL/PERMEABILITY-INCREASING FACTOR, DEFENSINS, AND NEUTROPHIL EXTRACELLULAR TRAPS (NETs)
- PLATELET-ACTIVATING FACTOR
- NITRIC OXIDE
- NANOTECHONOLOGY AND OTHER NOVEL TECHNIQUES
- CONCLUSION
- 259. Probiotics
- DEFINITIONS
- MECHANISM OF ACTION
- PROBIOTICS AND PREBIOTICS FOR PREVENTION AND TREATMENT OF CLINICAL CONDITIONS
- SAFETY OF PROBIOTICS AND PREBIOTICS IN INFANTS AND CHILDREN
- INFECTIOUS DISEASES RELATED TO PROBIOTIC USE
- Part V. Prevention of Infectious Diseases
- 260. Health Care–Associated Infections
- HISTORICAL BACKGROUND
- SPREAD OF COMMUNICABLE INFECTIONS IN HEALTH CARE FACILITIES
- HEALTH CARE–ASSOCIATED INFECTIONS DUE TO INVASIVE DEVICES AND PROCEDURES
- HEALTH CARE–ASSOCIATED INFECTIONS CAUSED BY SPECIAL PATHOGENS
- HEALTH CARE–ASSOCIATED INFECTIONS IN SPECIAL POPULATIONS
- HEALTH CARE EPIDEMIOLOGY AND INFECTION PREVENTION AND CONTROL PROGRAMS IN HEALTH CARE FACILITIES
- 261. Antimicrobial Stewardship
- CONSEQUENCES OF ANTIBIOTIC USE
- ANTIMICROBIAL PRESCRIBING
- POLICY IMPLICATIONS
- INPATIENT ANTIMICROBIAL STEWARDSHIP
- OUTPATIENT ANTIMICROBIAL STEWARDSHIP
- ADDITIONAL HEALTH CARE SETTINGS
- ADDITIONAL CONSIDERATIONS
- 262. Active Immunizing Agents
- ACTIVE IMMUNOPROPHYLAXIS: CONSIDERATIONS AND RECOMMENDATIONS
- VACCINES RECOMMENDED FOR ROUTINE ADMINISTRATION
- VACCINES WITH SELECTIVE INDICATIONS FOR CHILDREN AND ADOLESCENTS
- 263. Passive Immunization
- PRINCIPLES OF PASSIVE IMMUNITY
- PASSIVE IMMUNITY IN BACTERIAL DISEASES
- PASSIVE IMMUNITY IN VIRAL INFECTIONS
- SARS-CoV-2
- Acknowledgments
- Section 24. Other Preventive Considerations
- 264. Public Health Aspects of Infectious Disease Control
- PUBLIC HEALTH AND INFECTIOUS DISEASE CLINICIANS
- PUBLIC HEALTH
- INFECTIOUS DISEASE SURVEILLANCE
- HOW PUBLIC HEALTH CAN ASSIST CLINICIANS
- OUTBREAK INVESTIGATION
- PUBLIC HEALTH PREVENTION AND CONTROL MEASURES
- COMMON PATTERNS OF DISEASE SPREAD
- EXAMPLES OF EXPOSURE SOURCES
- VECTOR-BORNE DISEASE
- COMMON DISEASE TRANSMISSION SETTINGS
- HEALTH INFORMATION FOR INTERNATIONAL TRAVEL
- SUMMARY
- 265. Infections in Out-of-Home Childcare
- FACTORS AFFECTING TRANSMISSION OF INFECTIOUS AGENTS
- MODES OF TRANSMISSION OF INFECTIOUS DISEASES IN OUT-OF-HOME CHILDCARE
- PREVENTION AND CONTROL OF INFECTIONS IN OUT-OF-HOME CHILDCARE
- INFECTIOUS AGENTS IN CHILDCARE
- 266. Animal and Human Bites
- HISTORICAL ASPECTS
- EPIDEMIOLOGY
- MICROBIOLOGY
- CLINICAL MANIFESTATIONS
- DIAGNOSIS AND TREATMENT
- REPTILE BITES
- PREVENTION
- 267. Bioterrorism
- HISTORY
- EPIDEMIOLOGY
- PREPAREDNESS AND RESPONSE
- CRITICAL BIOLOGIC AGENTS
- Part VI. Approach to the Laboratory Diagnosis of Infectious Diseases
- 268. Bacterial Laboratory Diagnosis
- CULTURE-BASED DETECTION
- Antimicrobial Susceptibility Testing
- NON–CULTURE-BASED DETECTION METHODS
- 269. Fungal Diagnostics for Pediatric Patients
- PREANALYTICAL CONSIDERATIONS
- CULTURE-DEPENDENT METHODS FOR THE DETECTION OF IFDs
- CULTURE-INDEPENDENT METHODS FOR THE DETECTION OF IFDs
- ANTIFUNGAL SUSCEPTIBILITY TESTING
- POSTANALYTICAL CONSIDERATIONS
- 270. Viral Laboratory Diagnosis
- Specimen Collection and Transport
- Laboratory Diagnosis of Viral Infections
- SARS-CoV-2 Diagnostics
- Summary
- Acknowledgment
- 271. Parasitic Laboratory Diagnosis
- STOOL-BASED DETECTION
- Processing of Stool Samples
- Other Tissue or Body Fluids for Parasite Detection
- Blood Parasites
- Molecular Testing
- Index
- No. of pages: 3184
- Language: English
- Edition: 9
- Published: August 29, 2024
- Imprint: Elsevier
- Hardback ISBN: 9780323827638
- eBook ISBN: 9780323827645
JC
James Cherry
James D. Cherry, MD, MSc is a Distinguished Research Professor at the David Geffen School of Medicine at UCLA and UCLA Mattel Children’s Hospital, Division of Infectious Diseases. Dr. Cherry established one of the first formal pediatric infectious disease fellowship programs in the world in 1963 at the University of Wisconsin. In 1973 Dr. Cherry started the first pediatric infectious training program at UCLA. During his 43 years tenure at UCLA, numerous trainees have gone on to be leaders in pediatric infectious diseases in the US and around the world. Dr. Cherry has won many awards during his career.
Affiliations and expertise
Distinguished Professor of Pediatrics, David Geffen School of Medicine at UCLA; Attending Physician, Pediatric Infectious Diseases, Mattel Children’s Hospital UCLA, Los Angeles, CaliforniaSK
Sheldon L. Kaplan
Affiliations and expertise
Professor, Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine; Attending Physician, Infectious Disease Service, Texas Children’s Hospital, Houston, TexasGD
Gail J. Demmler-Harrison
Affiliations and expertise
Professor, Department of Pediatrics, Division of Infectious Diseases, Baylor College of Medicine; Attending Physician, Infectious Diseases Service, Texas Children’s Hospital, Houston, TexasWS
William Steinbach
Affiliations and expertise
Professor of Pediatrics, Robert H. Fiser, Jr., MD Endowed Chair in Pediatrics, Chair, Department of Pediatrics, Associate Dean for Child Health, College of Medicine, University of Arkansas for Medical Sciences; Pediatrician-in-Chief, Arkansas Children’s Little Rock, ArkansasPH
Peter J Hotez
Affiliations and expertise
Dean, National School of Tropical Medicine, Professor, Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine; Endowed Chair of Tropical Pediatrics, Texas Children’s Hospital, Houston, TexasJW
John V Williams
John V. Williams, MD, a leading expert on respiratory viruses that infect children, is chair of the Department of Pediatrics at the University of Wisconsin School of Medicine and Public Health.
Affiliations and expertise
Professor and Chair, Department of Pediatrics and Microbiology & Molecular Genetics, Henry L. Hillman Professor of Pediatrics, University of Wisconsin School of MedicineRead Feigin and Cherry's Textbook of Pediatric Infectious Diseases on ScienceDirect